Background aims We have previously demonstrated the safety and feasibility of adoptive
cell therapy with CD45RA− memory T cells containing severe acute respiratory syndrome …

As of 2021 November 29, booster vaccination against SARS-CoV-2 infection has been
recommended for all individuals aged 18 years and older in the United States. A key reason …

Highlights•Significant inequity is observed in vaccine distribution and administration
worldwide.•Delta variant dominance and waning vaccine efficacy against infection raise the …

Abstract The World Health Organization has stated that the primary goal of immunisation in
the COVID‐19 pandemic remains to protect against hospitalisation, severe disease and …

Recent reports on waning of COVID-19 vaccine induced immunity have led to the approval
and roll-out of additional dose and booster vaccinations. At risk individuals are receiving …

Still, countries not only need to properly monitor the effectiveness of their vaccination
campaigns, but can gain a lot by thinking about smart allocation strategies for upcoming …

Abstract During July–August 2021, a coronavirus disease 2019 (COVID-19) outbreak
involving 21 residents (all fully vaccinated) and 10 staff (9 fully vaccinated) occurred in a …

Amid the ongoing global COVID-19 pandemic, limited literature exists on immune
persistence after primary immunization and the immunogenic features of booster vaccines …

The novel coronavirus disease of 2019 (COVID-19) vaccination is a critical prevention
measure to help sort out the COVID-19 crisis. Nonetheless, since the beginning of the …

Concerns about the duration of protection conferred by COVID-19 vaccines have arisen in
postlicensure evaluations. However,“depletion of susceptibles” bias driven by differential …